Search research articles
Contact Us
Filters
Showing results (41-50 of 371) with videos related to
Page
of 38
Sort By:
International Journal of Cancer
|
September 15, 1988
Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma
R Fåhraeus, H L Fu, I Ernberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1993
Leukemoid reaction, bone marrow invasion, fever of unknown origin, and metastatic pattern in the natural history of advanced undifferentiated carcinoma of nasopharyngeal type: a review of 255 consecutive cases
E Cvitkovic, M Bachouchi, H Boussen, et al.
Head & Neck
|
March 1, 1993
Phase II trial of recombinant interferon gamma in refractory undifferentiated carcinoma of the nasopharynx
R Mahjoubi, M Bachouchi, J N Munck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1993
Clinical implications of the serum level of CD23 in patients with undifferentiated nasopharyngeal carcinoma
G Rousselet, M Bachouchi, P Busson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
Chromosome 11q13 gene amplifications in oral and oropharyngeal carcinomas: no correlation with subclinical lymph node invasion and disease recurrence
A Fortin, M Guerry, R Guerry, et al.
Cancer Research
|
February 24, 1999
Control of apoptosis in Epstein Barr virus-positive nasopharyngeal carcinoma cells: opposite effects of CD95 and CD40 stimulation
F Sbih-Lammali, B Clausse, H Ardila-Osorio, et al.
International Journal of Cancer
|
April 1, 1992
Elevated expression of ICAM1 (CD54) and minimal expression of LFA3 (CD58) in Epstein-Barr-virus-positive nasopharyngeal carcinoma cells
P Busson, Q Zhang, J M Guillon, et al.
The EMBO Journal
|
September 1, 1989
EBV gene expression in an NPC-related tumour
M M Hitt, M J Allday, T Hara, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
August 11, 2007
[Expression of c-kit in North African nasopharyngeal carcinomas: correlation with age and LMP1]
S Charfi, A Khabir, L Ayadi, et al.
Journal of Virology
|
October 1, 1989
Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2
M Billaud, P Busson, D Huang, et al.
Page
of 38
Search research articles
Search
Showing results (41-50 of 371) with videos related to
Sort By:
Page
of 38
International Journal of Cancer
|
September 15, 1988
Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma
R Fåhraeus, H L Fu, I Ernberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1993
Leukemoid reaction, bone marrow invasion, fever of unknown origin, and metastatic pattern in the natural history of advanced undifferentiated carcinoma of nasopharyngeal type: a review of 255 consecutive cases
E Cvitkovic, M Bachouchi, H Boussen, et al.
Head & Neck
|
March 1, 1993
Phase II trial of recombinant interferon gamma in refractory undifferentiated carcinoma of the nasopharynx
R Mahjoubi, M Bachouchi, J N Munck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1993
Clinical implications of the serum level of CD23 in patients with undifferentiated nasopharyngeal carcinoma
G Rousselet, M Bachouchi, P Busson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
Chromosome 11q13 gene amplifications in oral and oropharyngeal carcinomas: no correlation with subclinical lymph node invasion and disease recurrence
A Fortin, M Guerry, R Guerry, et al.
Cancer Research
|
February 24, 1999
Control of apoptosis in Epstein Barr virus-positive nasopharyngeal carcinoma cells: opposite effects of CD95 and CD40 stimulation
F Sbih-Lammali, B Clausse, H Ardila-Osorio, et al.
International Journal of Cancer
|
April 1, 1992
Elevated expression of ICAM1 (CD54) and minimal expression of LFA3 (CD58) in Epstein-Barr-virus-positive nasopharyngeal carcinoma cells
P Busson, Q Zhang, J M Guillon, et al.
The EMBO Journal
|
September 1, 1989
EBV gene expression in an NPC-related tumour
M M Hitt, M J Allday, T Hara, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
August 11, 2007
[Expression of c-kit in North African nasopharyngeal carcinomas: correlation with age and LMP1]
S Charfi, A Khabir, L Ayadi, et al.
Journal of Virology
|
October 1, 1989
Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2
M Billaud, P Busson, D Huang, et al.
Page
of 38